Abstract
The duodenoscope, a complex endoscopic instrument, is frequently utilized to accomplish the increasing demand for minimally invasive treatments of pancreatic and biliary diseases. It is, in addition, the fundamental tool used to perform endoscopic retrograde cholangiopancreatography (ERCP). However, outbreaks of multidrug resistance organism transmission have occurred in patients undergoing ERCP while adherent to current endoscope manufacturers’ reprocessing guidelines. Evolving evidence suggests that implementation of the current protocols is inadequate to guarantee a pathogen-free duodenoscope. In spite of infection risk, ERCP remains a critical platform in the management of patients with pancreaticobiliary diseases. This manuscript reviews the history and epidemiology of recent duodenoscope-related infections, current challenges to scope reprocessing, and recommendations by regulatory agencies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
